Hans Schlosser

12PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 29, 2026
Geriatric co-managed prehabilitation before esophagectomy in patients aged ≥ 65 years with esophageal cancer: a prospective feasibility study with matched historical controls.

|Jul 11, 2025
Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.

Hans N C Eckel, Su Ir Lyu, Frederik Faste

|Dec 11, 2024
Tertiary Lymphoid Structures in Pancreatic Cancer are Structurally Homologous, Share Gene Expression Patterns and B-cell Clones with Secondary Lymphoid Organs, but Show Increased T-cell Activation.

Jonas Lehmann, Martin Thelen, Christoph Kreer

|Oct 25, 2024
Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles.

Milita Darguzyte, Philipp Antczak, Daniel Bachurski

|Apr 27, 2024
Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats.

Patrick Schmidt, Johannes Lindemeyer, Pranali Raut

|Feb 04, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.

Sibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute

Pageof 2

Frequent Collaborators

6 joint publications

Martin Thelen

3 joint publications

Maria A Garcia-Marquez

3 joint publications

Christiane J Bruns

3 joint publications

Alexander Quaas